je.st
news
Tag: cancer
PsiOxus Therapeutics to Release Study Results of Oncolytic Vaccine Enadenotucirev in Cancer Patients
2014-05-13 11:58:44| Logistics - Topix.net
The EVOLVE trial is a phase I/II trial of intravenous administration of enadenotucirev to patients with epithelial cancers and the MoA trial is a phase I "window of opportunity" trial evaluating intravenous and intra-tumoural administration of enadenotucirev to patients with colon cancer.
Tags: results
study
release
cancer
From One Rancher To Another: Be Proactive About Preventing Skin Cancer
2014-05-05 23:35:32| Beef
May is Skin Cancer Awareness Month, and before you stop reading this blog, thinking its an issue of no concern to you, think again. According to the Skin Cancer Foundation, Skin cancer is the most common form of cancer in the U.S. More than 3.5 million skin cancers in over 2 million people are diagnosed annually. Each year there are more new cases of skin cancer than the combined incidence of cancers of the breast, prostate, lung and colon. One in five Americans will get skin cancer in their lifetime. BEEF Daily read more
Tags: skin
cancer
preventing
proactive
Endocyte's ovarian cancer drug fails trial, shares sink
2014-05-04 10:59:52| Biotech - Topix.net
Merck & Co Inc and Endocyte Inc said they had stopped a late-stage trial of their experimental ovarian cancer drug as it failed to improve survival rates without the cancer worsening, sending Endocyte's shares tumbling as much as 63 percent.
Tags: trial
drug
cancer
shares
SRI International Announces PDCellX Xenograft Tumor Model Services To Accelerate Cancer Drug Research
2014-04-30 07:22:26| drugdiscoveryonline News Articles
SRI International has announced the availability of its PDCellX™ xenograft tumor model services for testing the activity of potential cancer therapeutics
Tags: services
international
research
model
BPS Bioscience, Inc. Introduces New Mutant EZH2 Proteins And Assays Now Available For Cancer And Weaver Syndrome Research
2014-04-30 07:01:39| drugdiscoveryonline News Articles
BPS Bioscience, Inc. (BPS) is excited to announce a unique portfolio of 13 different mutant EZH2 complexes, including several markers for Weaver Syndrome
Tags: research
cancer
proteins
syndrome
Sites : [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] next »